Ticker,Title,Link
ARCH,Arch Resources slips after Consol merger news; Jefferies sees timing 'not ideal',8/21/2024 7:19:23 PM
ARCH,Arch Biopartners’ Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting Acute Kidney Injury Caused by Drug Toxins,8/2/2024 1:20:00 PM
ARCH,Arch Biopartners Closes Non-Brokered Private Placement,7/30/2024 10:47:28 PM
ARCH,Arch Biopartners Arranges Non-Brokered Private Placement,7/29/2024 10:52:28 PM
ARCH,Market Perform Rating Maintained for Arch Resources Amid Mixed Results and Operational Risks,7/26/2024 11:18:08 AM
ARCH,"ARCH Stock Earnings: Arch Resources Misses EPS, Beats Revenue for Q2 2024",7/25/2024 3:55:01 PM
ARCH,Arch Resources Q2 2024 Earnings Preview,7/24/2024 4:23:34 PM
ARCH,Benchmark Co. Sticks to Their Buy Rating for Arch Resources (ARCH),7/23/2024 11:55:49 AM
ARCH,3 Coal Stocks to Leave in the Dirt as Wind Power Soars,7/22/2024 7:50:37 PM
ARCH,"Peabody Energy, coal stocks surge after major mine outage, Supreme Court rulings",7/1/2024 8:47:30 PM
ARCH,Arch Biopartners Announces GMP Manufacturing of Cilastatin Drug Product,6/27/2024 1:25:00 PM
ARCH,Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI),6/18/2024 1:35:00 PM
ARCH,Major world economies seeking to stop new private sector coal financing - Reuters,6/9/2024 12:45:00 AM
ARCH,"Analysts Offer Insights on Materials Companies: Teck Resources (TECK), Arch Resources (ARCH) and Agnico Eagle (AEM)",4/26/2024 11:31:38 AM
ARCH,"ARCH Stock Earnings: Arch Resources Misses EPS, Beats Revenue for Q1 2024",4/25/2024 3:55:55 PM
ARCH,Arch Resources Q1 2024 Earnings Preview,4/24/2024 6:16:59 PM
ARCH,Earnings Minefield: The 3 Stock Landmines to Avoid This Quarter,4/22/2024 5:30:11 PM
ARCH,3 Coal Stocks to Sell Before Baltimore Port Disruptions Sink Profits,4/19/2024 10:49:00 AM
ARCH,Arch Resources cut at Citi on 10% free cash flow target,4/18/2024 6:29:37 PM
ARCH,St. Michael’s Hospital Joins the Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury,4/16/2024 1:14:00 PM
ARCH,Goldilocks Investing: 7 Mid-Cap Stocks That Are Just Right,4/14/2024 6:27:42 PM
ARCH,Beyond The Numbers: 5 Analysts Discuss Arch Resources Stock,4/11/2024 8:01:50 PM
ARCH,"Arch Resources cut at BMO on Baltimore port shutdown, declining HVA prices",4/10/2024 7:32:51 PM
ARCH,EIA cuts April coal export forecast by a third following Baltimore bridge collapse,4/9/2024 11:44:34 PM
ARCH,UHN Joins the Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury,4/3/2024 1:00:00 PM
ARCH,Arch Biopartners Adds Three New Clinical Sites into the Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury,4/2/2024 1:26:00 PM
ARCH,Consol Energy slides 7% as Maryland marine terminal likely faces long downtime,3/26/2024 7:30:17 PM
ARCH,Arch Biopartners Clinical Team Publishes Data from Phase II Trial for LSALT Peptide Targeting Organ Inflammation in Hospitalized Patients Infected with SARS-CoV-2,3/18/2024 12:28:00 PM
ARCH,U.S. considers rule compelling faster closure of some coal plants - Bloomberg,3/15/2024 5:23:09 PM
ARCH,B. Riley Securities Maintains Buy Rating for Arch Resources: Here's What You Need To Know,3/12/2024 6:00:25 PM
ARCH,Arch Biopartners Announces Dosing of First Patient in Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury,3/7/2024 1:26:00 PM
ARCH,Arch Biopartners Has Pre-IND Meeting With FDA to Discuss Repurposing Cilastatin as a New Treatment to Prevent Acute Kidney Injury,2/27/2024 1:25:00 PM
ARCH,"Analysts’ Top Materials Picks: Arch Resources (ARCH), Agnico Eagle (AEM)",2/16/2024 12:32:53 PM
ARCH,Arch Resources declares $0.25 dividend & variable dividend of $1.40,2/15/2024 2:34:28 PM
ARCH,Arch Resources Q4 2023 Earnings Preview,2/14/2024 3:49:59 PM
ARCH,7 High-Growth Stocks to Snag for Spectacular Returns in 2024,2/6/2024 8:51:41 PM
ARCH,3 Stocks to Sidestep in 2024 if Democrats Keep the White House,1/11/2024 1:29:40 PM
ARCH,Arch Biopartners Receives Health Canada Approval to Conduct Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury,1/10/2024 1:26:00 PM
ARCH,Arch Biopartners Receives Approval from the Turkish Ministry of Health to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury,1/3/2024 1:33:00 PM
ARCH,"Analysts Offer Insights on Materials Companies: Arch Resources (ARCH), Torex Gold Resources (OtherTORXF) and Sociedad Quimica Y Minera SA (SQM)",1/2/2024 12:40:11 PM
ARCH,Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac Surgery Associated-Acute Kidney Injury Trial for LSALT Peptide,12/21/2023 1:30:00 PM
ARCH,Grant of Options to Directors and Officers,12/18/2023 2:25:00 PM
ARCH,Arch Biopartners Submits Application to Health Canada to Conduct the Phase II Cardiac Surgery Associated-Acute Kidney Injury Trial for LSALT Peptide,12/13/2023 1:25:00 PM
ARCH,5 Analysts Have This to Say About Arch Resources,11/17/2023 5:00:34 PM
ARCH,Arch Resources’ Strong Financial Performance and Commitment to Shareholder Returns Warrant a Buy Rating,10/27/2023 11:38:08 AM
ARCH,Here's what Wall Street expects from Arch Resources A's earnings,10/25/2023 3:01:13 PM
ARCH,Shares for Interest Debt Settlement,10/24/2023 1:30:00 PM
ARCH,Arch Resources Unlikely To Reach 10M Watermark Before 2025 - Analyst,10/3/2023 10:35:55 PM
ARCH,Why Intelligent Bio Solutions Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session,10/2/2023 7:01:18 PM
ARCH,Arch Biopartners Submits Application to the Turkish Ministry of Health to Conduct a Phase II Cardiac Surgery Associated-Acute Kidney Injury Trial for LSALT Peptide,9/22/2023 1:00:00 PM
ARCH,Top 5 Energy Stocks That You May Want To Dump In September,9/19/2023 2:34:27 PM
ARCH,Arch Resources goes ex dividend tomorrow,8/29/2023 5:58:10 PM
ARCH,The 7 Best Value Stocks to Buy in August,8/11/2023 1:15:18 AM
ARCH,BMO Capital Remains a Buy on Arch Resources (ARCH),7/28/2023 11:45:17 AM
ARCH,"Arch Resources GAAP EPS of $4.04 misses by $1.58, revenue of $757.29M beats by $87.12M",7/27/2023 10:58:46 AM
ARCH,Arch Resources Q2 2023 Earnings Preview,7/26/2023 4:20:27 PM
ARCH,3 Bulletproof Stocks to Own Forever,7/12/2023 1:09:58 AM
ARCH,"Arch Resources declares $0.25 dividend, special dividend of $2.20",4/27/2023 2:28:40 PM
ARCH,Arch Resources Q1 2023 Earnings Preview,4/26/2023 6:24:38 PM
ARCH,7 Energy Stocks to Buy at Discount Prices,4/3/2023 9:09:33 PM
ARCH,7 Energy Stocks Sitting in the Sweet Spot,3/22/2023 11:05:16 PM
ARCH,"Oil prices tumbled this week on amped-up rate hike worries, supply glut",2/18/2023 1:05:56 AM
ARCH,Dow Down 100 Points; RingCentral Shares Plummet,2/16/2023 8:40:46 PM
ARCH,Arch Resources Q4 2022 Earnings Preview,2/15/2023 6:52:54 PM
ARCH,"Teck Resources cut at B. Riley on valuation, preferring Arch, Alpha Natural",1/17/2023 5:35:16 PM
ARCH,7 Under-the-Radar Energy Stocks With 40% Upside Potential,1/12/2023 8:43:45 PM
ARCH,"Benzinga's Top Ratings Upgrades, Downgrades For January 11, 2023",1/11/2023 4:01:02 PM
ARCH,"Not Exxon, Not Occidental — Little-Known Indonesian Miner Is 2022's Best Performing Stock With Eye-Popping 1600% Gain",12/15/2022 10:45:35 AM
ARCH,Trump announces 2024 presidential bid; here are stocks that might benefit,11/16/2022 1:59:50 AM
ARCH,Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday,10/28/2022 10:57:46 AM
ARCH,Arch Resources among Energy/Material gainers; McEwen Mining and CNX Resources among losers,10/27/2022 6:00:49 PM
ARCH,Arch Coal Q3 2022 Earnings Preview,10/26/2022 4:40:15 PM
ARCH,Europe coal price spikes as South Africa strike whacks supply,10/12/2022 6:55:02 PM
ARCH,Arch Biopartners Adds Farris Smith as a Strategic Advisor,10/5/2022 1:20:00 PM
ARCH,Coal producers surge as U.S. coal price tops $200/ton,10/3/2022 7:25:04 PM
ARCH,The 3 Best Coal Stocks to Buy Now,9/29/2022 8:15:24 PM
ARCH,7 Growth Stocks to Buy Before the Bull Market Returns,9/28/2022 10:00:36 AM
ARCH,The 7 Best Commodity Stocks for Rising Inflation,9/19/2022 5:24:14 PM
ARCH,7 Small-Cap Stocks to Buy Before September Ends,9/15/2022 3:54:49 PM
ARCH,"Hydropower is Out; Coal and Battery Power are In. Check Out BTU, ARCH, and RUN Stocks",9/12/2022 1:19:46 PM
ARCH,The 3 Best Mining Stocks to Buy Now,9/7/2022 5:30:12 PM
ARCH,Why Nikola Dropped Over 9%; Here Are 66 Biggest Movers From Yesterday,8/31/2022 11:50:17 AM
ARCH,"Baidu, Nikola And Some Other Big Stocks Moving Lower On Tuesday",8/30/2022 5:35:21 PM
ARCH,"Arch Biopartners Adds Dr. David Luke as a Strategic Advisor, Clinical Trials",8/5/2022 1:30:00 PM
ARCH,Genesis among Energy/Material gainers; CNX Resources and Arch Resources among losers,7/28/2022 6:00:56 PM
ARCH,Arch Coal Q2 2022 Earnings Preview,7/27/2022 5:33:19 PM
ARCH,6 Best Coal Stocks to Buy Now,7/12/2022 5:27:52 PM
ARCH,3 Hot Stocks to Buy Now,7/9/2022 10:32:45 AM
ARCH,Natural gas posts worst daily loss in 19 years after Freeport LNG restart delay,6/30/2022 9:20:35 PM
ARCH,7 Coal Stocks to Buy on Red-Hot Sentiment,6/20/2022 11:01:53 AM
ARCH,Exxon surges within a dollar of its all-time closing high as analysts jump in,6/7/2022 9:45:03 PM
ARCH,7 Mid-Cap Stocks to Buy for Massive Growth,6/2/2022 1:53:35 PM
ARCH,Southwestern and Peabody shares lifted by 14-year high in natural gas prices,5/23/2022 7:54:07 PM
ARCH,Domestic coal price charts form space needle pattern,5/18/2022 5:21:12 PM
ARCH,Are energy investors fading the rally in commodity prices?,5/16/2022 7:28:50 PM
ARCH,Q1 energy earnings review - what did we learn?,5/11/2022 4:37:20 PM
ARCH,Peabody after the call - buy a business any fool can run,4/28/2022 4:45:55 PM
ARCH,"Energy equities bounce, as oil trade sideways and coal stocks take off",4/27/2022 7:29:34 PM
ARCH,"Russia to cut off gas to Bulgaria, White House concerned about Iranian nuke",4/26/2022 8:58:15 PM
ARCH,Arch Coal Q1 2022 Earnings Preview,4/25/2022 5:21:16 PM
ARCH,Arcadia Biosciences among Energy/Material gainers; Uranium Energy and Arch Resources among losers,4/22/2022 6:00:20 PM
ARCH,3 Coal Stocks to Buy Ahead of Proposed Russia Ban,4/14/2022 10:34:55 PM
ARCH,Coal mining shares surge as Europe's Russia coal ban takes effect,4/12/2022 5:44:12 PM
ARCH,"Coal Stocks Alert: Why Are BTU, ARCH, CEIX Stocks in the Spotlight Today?",4/5/2022 7:43:36 PM
ARCH,What Wall Street expects from Arch Resources A's earnings,2/14/2022 3:01:13 PM
ARCH,Shares for Interest Debt Settlement,2/9/2022 1:44:02 AM
ARCH,Arch Scientists Publish Data on the Mechanism of Action and Efficacy of Lead Drug Candidate LSALT Peptide in the Prevention of Acute Kidney Injury,2/3/2022 1:30:00 PM
ARCH,Research Ethics Board approves amendment to Canadian Treatments for COVID-19 (CATCO) Trial to include LSALT Peptide (Metablok),1/4/2022 1:25:00 PM
ARCH,Arch Biopartners’ Lead Drug LSALT Peptide to Enter the Canadian Treatments for COVID-19 (CATCO) Trial,12/1/2021 1:35:00 PM
ARCH,"Arch Resources, Inc. -- Moody's revises Arch Resources' outlook to positive; affirms B2 CFR",11/5/2021 1:18:00 AM
ARCH,Unaware of Any Undisclosed Material Change,10/15/2021 4:42:18 PM
ARCH,"Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2021",9/29/2021 4:11:58 PM
ARCH,Mid-Morning Market Update: Markets Mixed; US Durable Goods Orders Increase Sharply In August,9/27/2021 4:15:51 PM
ARCH,Arch Biopartners Provides Update on Phase II Trial for LSALT Peptide,8/5/2021 12:30:00 PM
ARCH,Arch Resources Reports Second Quarter 2021 Results,7/27/2021 12:30:00 PM
ARCH,Arch Resources A is about to announce its earnings — here's what to expect,7/25/2021 3:01:45 PM
ARCH,"Arch Resources, Inc. -- Moody's announces completion of a periodic review of ratings of Arch Resources, Inc.",7/22/2021 8:56:00 PM
ARCH,Arch Scientists Awarded CIHR Grant to Study LSALT for the Prevention of Chronic Disease,7/14/2021 1:00:00 PM
ARCH,Arch Resources to Announce Second Quarter 2021 Results on July 27,7/12/2021 1:00:00 PM
ARCH,Arch Biopartners Files New Patent Application for Novel Antibody Candidates Targeting DPEP-1 Mediated Organ Inflammation,6/10/2021 1:20:00 PM
ARCH,Arch Biopartners Completes Enrollment in Phase II Trial of Metablok (LSALT Peptide) in Hospitalized Patients with COVID-19,5/4/2021 1:00:00 PM
ARCH,Arch Resources A earnings preview: what Wall Street is expecting,4/20/2021 3:01:31 PM
ARCH,Arch Biopartners Enters into Worldwide License Agreement with Telara Pharma to Re-Purpose Cilastatin for the Treatment and Prevention of Acute Kidney Injury,4/15/2021 1:00:00 PM
ARCH,Turkish Ministry of Health Approves Increase in Patient Recruitment into the Phase II Trial for LSALT Peptide,3/30/2021 1:57:22 PM
ARCH,Arch Biopartners Enters Exclusive License Agreement with the University of Cincinnati for AB569 Topical Wound Treatment,3/24/2021 1:25:45 PM
ARCH,3 Short Squeeze Candidates In The Energy Sector,3/23/2021 6:41:01 PM
ARCH,Arch Biopartners Receives Health Canada Authorization to Amend Phase II Trial Protocol for LSALT Peptide,3/16/2021 1:32:59 PM
ARCH,ARCH Scientist Publishes Paper Showing Pre-Clinical Efficacy of AB569 in Eradicating Multi-Drug Resistant Pathogens Acinetobacter baumannii and Acinetobacter spp,3/4/2021 2:32:46 PM
ARCH,Peter Lougheed Centre Joins the Phase II Trial of LSALT Peptide for the Treatment of Complications in Hospitalized COVID-19 Patients,2/26/2021 2:42:46 PM
ARCH,"The Past Week's Notable Insider Buys: Biotech IPOs, Curiositystream, Greenbrier And More",2/13/2021 6:54:39 PM
ARCH,Arch Biopartners Receives Ethics Committee Approval in Turkey to Dose Additional Patients in the Phase II Trial for LSALT Peptide,2/2/2021 1:55:54 PM
ARCH,Arch Resources Inc Registered Shs -A- hosts conference call for investors,1/29/2021 3:02:42 PM
ARCH,University of Calgary Joins the Phase II Trial of LSALT Peptide for the Treatment of Complications in Hospitalized COVID-19 Patients,1/5/2021 1:50:00 PM
ARCH,Arch Biopartners Closes Non-Brokered Private Placement,12/29/2020 2:33:20 PM
ARCH,Arch Biopartners Arranges Non-Brokered Private Placement,12/23/2020 2:53:07 PM
ARCH,Arch Biopartners Receives Government of Canada Funding to Support Phase II Therapeutic Trial of Metablok for COVID-19,12/15/2020 6:51:42 PM
ARCH,VA San Diego Healthcare System Joins the Phase II Trial of LSALT Peptide for the Treatment of Complications in Hospitalized COVID-19 Patients,12/10/2020 1:27:00 PM
ARCH,Arch Biopartners Announces Dosing of First Patient in Turkey in Phase II Trial of LSALT peptide to Treat Complications from Covid-19,11/5/2020 2:03:49 PM
ARCH,What Wall Street expects from Arch Resources A's earnings,10/21/2020 3:01:38 PM
ARCH,First Patient Dosed in Phase II Trial to Treat Complications in COVID-19,10/16/2020 1:00:10 PM
ARCH,Arch Biopartners Receives Approval from Turkish Ministry of Health to Proceed with Phase II Trial for LSALT Peptide; Begins Screening Patients in Florida,10/7/2020 1:57:56 PM
ARCH,Arch Biopartners Announces Application to the Turkish Ministry of Health to Conduct Phase II Trial for Treatment of Complications in COVID-19 patients,9/1/2020 2:00:10 PM
ARCH,Arch Biopartners Obtains DTC Eligibility for its Common Shares on OTCQB,8/21/2020 2:00:10 PM
ARCH,"Arch Biopartners to Hold LSALT Peptide Webinar and Q&A Session August 18, 2020 at 11am EST ",8/7/2020 5:34:41 PM
ARCH,Arch Biopartners Receives Independent Institutional Review Board Approval for Phase II Trial for LSALT Peptide,8/4/2020 2:00:10 PM
ARCH,Broward Health Medical Center Becomes First Clinical Site in U.S. for Phase II Trial for LSALT Peptide,7/28/2020 2:13:47 PM
ARCH,Here's what Wall Street expects from Arch Resources A's earnings report,7/27/2020 3:01:45 PM
ARCH,Arch Biopartners Engages Global CRO to Conduct LSALT peptide (Metablok) Phase II trial for Treatment of Complications in COVID-19 Patients in the U.S.,7/14/2020 1:00:10 PM
ARCH,FDA Grants Arch Biopartners Permission to Proceed with Phase II trial to Evaluate Metablok (LSALT peptide) for the Treatment of COVID-19 patients,6/16/2020 4:48:39 PM
ARCH,Arch Biopartners Announces FDA Acknowledgement of its Investigational New Drug Application for Metablok (LSALT peptide),6/15/2020 2:19:30 PM
ARCH,Arch Biopartners Submits Investigational New Drug Application to the FDA for Metablok (LSALT peptide),6/8/2020 1:00:10 PM
ARCH,Arch Biopartners Expands the Primary Endpoint of its Phase II Trial to Include Prevention of Multiple Organ Injuries in Patients with COVID-19,5/19/2020 10:31:38 PM
ARCH,Arch Biopartners Receives Health Canada Approval to Conduct COVID-19 Phase II Human Trial,5/8/2020 12:00:10 PM
ARCH,Arch Biopartners Submits Application to Health Canada to Conduct COVID19 Phase II Human Trial for Metablok to Prevent Lung and Kidney Inflammation,4/23/2020 10:54:56 PM
ARCH,Arch Biopartners Releases New Video Showing Metablok Reducing Lung Inflammation in an Animal Model,3/31/2020 1:36:20 PM
ARCH,ARCH BIOPARTNERS DISCLOSES NEW PATENT FILING FOR NOVEL DRUG CANDIDATES TO PREVENT LUNG INFLAMMATION,3/24/2020 12:27:10 PM
ARCH,ARCH BIOPARTNERS SAFELY COMPLETES  EXPANDED DOSING OF METABLOK IN PHASE I HUMAN TRIAL AND BEGINS FOCUS ON PHASE II TRIAL,3/17/2020 4:21:43 PM
ARCH,Arch Biopartners Expands Dosing in Phase I Trial for Metablok to Increase Dose Range for Future Phase II Studies,3/4/2020 3:56:29 PM
ARCH,Arch Scientist Publishes Data on the Pre-Clinical Efficacy of AB569 in Killing of Drug Resistant Bacteria,2/21/2020 2:00:00 PM
ARCH,Arch Biopartners Announces Metablok Achieves Primary Endpoints of Safety and Tolerability in Phase I Trial,12/18/2019 3:27:21 PM
